Fréderic Fina

3.1k total citations
87 papers, 2.2k citations indexed

About

Fréderic Fina is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Fréderic Fina has authored 87 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 29 papers in Molecular Biology and 27 papers in Cancer Research. Recurrent topics in Fréderic Fina's work include Glioma Diagnosis and Treatment (21 papers), Cancer Genomics and Diagnostics (18 papers) and Lung Cancer Treatments and Mutations (9 papers). Fréderic Fina is often cited by papers focused on Glioma Diagnosis and Treatment (21 papers), Cancer Genomics and Diagnostics (18 papers) and Lung Cancer Treatments and Mutations (9 papers). Fréderic Fina collaborates with scholars based in France, United States and Switzerland. Fréderic Fina's co-authors include L’Houcine Ouafik, Dominique Figarella‐Branger, Carole Colin, Olivier Chinot, Isabelle Nanni, Pierre‐Marie Martin, Isabelle Nanni‐Metellus, Christine Delfino, Philippe Métellus and Anderson Loundou and has published in prestigious journals such as Journal of Clinical Oncology, Analytical Chemistry and Brain.

In The Last Decade

Fréderic Fina

86 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fréderic Fina France	27	893	719	687	506	389	87	2.2k
Nduka Amankulor United States	21	791 0.9×	943 1.3×	641 0.9×	510 1.0×	339 0.9×	56	2.4k
Deric M. Park United States	26	861 1.0×	568 0.8×	543 0.8×	490 1.0×	299 0.8×	54	2.1k
Arend Koch Germany	34	1.4k 1.6×	848 1.2×	415 0.6×	421 0.8×	260 0.7×	85	2.6k
Sherise D. Ferguson United States	26	519 0.6×	653 0.9×	441 0.6×	264 0.5×	513 1.3×	94	2.0k
Bárbara Meléndez Spain	22	859 1.0×	442 0.6×	439 0.6×	421 0.8×	241 0.6×	66	1.6k
Javier S. Castresana Spain	30	1.4k 1.6×	514 0.7×	708 1.0×	592 1.2×	371 1.0×	115	2.3k
Kazuhiko Mishima Japan	27	1.2k 1.3×	662 0.9×	1.3k 1.9×	353 0.7×	301 0.8×	90	2.9k
Gianluigi Zona Italy	28	1.1k 1.3×	666 0.9×	1.3k 1.9×	498 1.0×	250 0.6×	95	3.2k
Yu Yao China	33	1.1k 1.2×	1.1k 1.6×	893 1.3×	772 1.5×	563 1.4×	112	3.0k
Kazufumi Sato Japan	23	759 0.8×	840 1.2×	471 0.7×	457 0.9×	235 0.6×	82	2.1k

Countries citing papers authored by Fréderic Fina

Since Specialization

Citations

This map shows the geographic impact of Fréderic Fina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fréderic Fina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fréderic Fina more than expected).

Fields of papers citing papers by Fréderic Fina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fréderic Fina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fréderic Fina. The network helps show where Fréderic Fina may publish in the future.

Co-authorship network of co-authors of Fréderic Fina

This figure shows the co-authorship network connecting the top 25 collaborators of Fréderic Fina. A scholar is included among the top collaborators of Fréderic Fina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fréderic Fina. Fréderic Fina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salas, Sébastien, Frédéric Ginot, Laurent Greillier, et al.. (2024). 137P Long circulating-free DNA fragments predict early-progression (EP) and progression-free survival (PFS) in advanced carcinoma treated with immune-checkpoint inhibition (ICI): A new biomarker. Annals of Oncology. 35. S270–S270. 1 indexed citations

Métais, Alice, Romain Appay, Mélanie Pagès, et al.. (2021). Low‐grade epilepsy‐associated neuroepithelial tumours with a prominent oligodendroglioma‐like component: The diagnostic challenges. Neuropathology and Applied Neurobiology. 48(2). e12769–e12769. 8 indexed citations

Bancaud, Aurélien, Audrey Didelot, Fréderic Fina, et al.. (2018). BIABooster: Online DNA Concentration and Size Profiling with a Limit of Detection of 10 fg/μL and Application to High-Sensitivity Characterization of Circulating Cell-Free DNA. Analytical Chemistry. 90(6). 3766–3774. 31 indexed citations

Etchevers, Heather, Christian Rosé, Birgit Kahle, et al.. (2018). Giant congenital melanocytic nevus with vascular malformation and epidermal cysts associated with a somatic activating mutation in BRAF. Pigment Cell & Melanoma Research. 31(3). 437–441. 12 indexed citations

Appay, Romain, Fréderic Fina, Nicolas Macagno, et al.. (2018). Duplications of KIAA1549 and BRAF screening by Droplet Digital PCR from formalin-fixed paraffin-embedded DNA is an accurate alternative for KIAA1549-BRAF fusion detection in pilocytic astrocytomas. Modern Pathology. 31(10). 1490–1501. 29 indexed citations

Mercier, Cédric, Cindy Serdjebi, Fréderic Fina, et al.. (2015). Lethal toxicity after administration of azacytidine. Pharmacogenetics and Genomics. 25(6). 317–321. 11 indexed citations

Secq, Véronique, Fréderic Fina, Xavier Carcopino, et al.. (2014). Triple negative breast carcinoma EGFR amplification is not associated with EGFR, Kras or ALK mutations. British Journal of Cancer. 110(4). 1045–1052. 35 indexed citations

Mazouni, Chafika, Fréderic Fina, Sylvie Romain, et al.. (2014). Outcome of Epstein-Barr virus-associated primary breast cancer. Molecular and Clinical Oncology. 3(2). 295–298. 20 indexed citations

Mazouni, Chafika, Fréderic Fina, Sylvie Romain, et al.. (2014). Post-operative nomogram for predicting freedom from recurrence after surgery in localised breast cancer receiving adjuvant hormone therapy. Journal of Cancer Research and Clinical Oncology. 141(6). 1083–1088. 2 indexed citations

10.

Serdjebi, Cindy, Joseph Ciccolini, Fréderic Fina, et al.. (2014). Recipient/donor contradictory genotypes with impact on drug pharmacogenetics after liver transplant. Pharmacogenetics and Genomics. 24(10). 527–529. 3 indexed citations

11.

Métellus, Philippe, Isabelle Nanni‐Metellus, Christine Delfino, et al.. (2011). Prognostic Impact of CD133 mRNA Expression in 48 Glioblastoma Patients Treated with Concomitant Radiochemotherapy: A Prospective Patient Cohort at a Single Institution. Annals of Surgical Oncology. 18(10). 2937–2945. 51 indexed citations

12.

Jacot, William, Evelyne Lopez‐Crapez, Simon Thézenas, et al.. (2011). Lack of EGFR-activating mutations in European patients with triple-negative breast cancer could emphasise geographic and ethnic variations in breast cancer mutation profiles. Breast Cancer Research. 13(6). R133–R133. 38 indexed citations

13.

Tchoghandjian, Aurélie, C. Fernandez, Carole Colin, et al.. (2009). Pilocytic astrocytoma of the optic pathway: a tumour deriving from radial glia cells with a specific gene signature. Brain. 132(6). 1523–1535. 46 indexed citations

14.

Deville, Jean‐Laurent, Catherine Bartoli, Caroline Bérenguer, et al.. (2009). Expression and role of adrenomedullin in renal tumors and value of its mRNA levels as prognostic factor in clear‐cell renal carcinoma. International Journal of Cancer. 125(10). 2307–2315. 26 indexed citations

15.

Colin, Carole, Brigitte Voutsinos‐Porche, Isabelle Nanni, et al.. (2009). High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas. Acta Neuropathologica. 118(6). 745–754. 56 indexed citations

16.

Lassailly, François, Julien Mozziconacci, Tetsuro Noguchi, et al.. (2007). Comparison of a Selection of Rapid Automated DNA and RNA Extraction Technologies for Detection of Somatic or Constitutional Gene Abnormalities in Cancer Diagnosis. 5(1). 2–15. 3 indexed citations

17.

Labuhn, Martin, Vincent Vuaroqueaux, Fréderic Fina, et al.. (2006). Simultaneous quantitative detection of relevant biomarkers in breast cancer by quantitative real-time PCR. The International Journal of Biological Markers. 21(1). 30–39. 13 indexed citations

18.

Lamy, Pierre‐Jean, Isabelle Nanni, Fréderic Fina, et al.. (2006). Reliability and Discriminant Validity of HER2 Gene Quantification and Chromosome 17 Aneusomy Analysis by Real-Time PCR in Primary Breast Cancer. The International Journal of Biological Markers. 21(1). 20–29. 17 indexed citations

19.

Ouafik, L’Houcine, Françoise Boudouresque, Olivier Chinot, et al.. (2002). Neutralization of Adrenomedullin Inhibits the Growth of Human Glioblastoma Cell Lines in Vitro and Suppresses Tumor Xenograft Growth in Vivo. American Journal Of Pathology. 160(4). 1279–1292. 108 indexed citations

20.

Girard, Beatrice M., et al.. (2002). Regulation of neurotrophic peptide expression in sympathetic neurons: quantitative analysis using radioimmunoassay and real-time quantitative polymerase chain reaction. Regulatory Peptides. 109(1-3). 89–101. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact